New patent expiration for Teva Pharms drug SYNRIBO

Annual Drug Patent Expirations for SYNRIBO Synribo is a drug marketed by Teva Pharms Intl and is included in one NDA. It is available from one supplier. There are two… The post New patent expiration for Teva Pharms drug SYNRIBO appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog